CAAA617C12301 / RTOG-3517 / RGUP21042 / Novartis / Qiu
Research Question:
not to be listed
Basic Study Information
Purpose:
The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617
in combination with Standard of Care, versus Standard of Care alone, in adult male
patients with mHSPC. In this study, the SoC is defined as a combination of Androgen
Receptor Directed Therapy + Androgen Deprivation Therapy. Approximately 1126 patients
will be randomized in this study.
Location: University of Rochester Cancer Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Haoming Qiu
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search